Vivienne Milch, Medical Director at Cancer Australia, shared on LinkedIn:
“Proud to announce that our article, ‘IARC Perspective on Lung Cancer Screening’, has just been published in the New England Journal of Medicine. It summarises more than a year of intensive work by our international group of lung cancer screening experts in collaboration with the IARC/WHO secretariat.
Honoured to be a Sub-Group Chair, together with Harry J de Koning (Working Group Chair), Matthew Callister, Stephen Lam, and Phil Crosbie and to collaborate with the broader expert panel across the entire Working Group.
Grateful for the coordination and support of the IARC/WHO Secretariat: Beatrice Lauby-Secretan, Neamtiu Luciana, Daniela Mariosa, Xiaoshuang Feng, Roya Dolatkhah, Mahdi Sheikh Hilary Robbins and Mattias Johansson (among other contributors, including Hannah Jongebloed).
I would also like to acknowledge and thank Cancer Australia and the Australian Government Department of Health, Disability and Ageing for their ongoing support of lung cancer screening research and implementation efforts in Australia.”
Title: IARC Perspective on Lung Cancer Screening
Authors: Luciana Neamtiu, Matthew E.J. Callister, Philip Crosbie, Stephen Lam, Vivienne Milch, Daniela Mariosa, Xiaoshuang Feng, Roya Dolatkhah, Ali Saeed Al‑Zahrani, Zhandos Amankulov, Jean‑Luc Bulliard, Wendy A. Cooper, Luis Corrales, Paolo Giorgi Rossi, Rayjean J. Hung, Ella Kazerooni, Mengmeng Li, Peter Mazzone, Rafael Meza, Arn Migowski, Rachael L. Murray, Samantha L. Quaife, Robert C. Rintoul, Witold Rzyman, Wei Jie Seow, Abhishek Shankar, Mahdi Sheikh, Hilary A. Robbins, Mattias Johansson,Harry J. de Koning, Béatrice Lauby‑Secretan.
Read the full article.
This also can be interesting:
KEYNOTE-671: Perioperative Pembrolizumab Redefines Curative-Intent Therapy in Resectable NSCLC
